September 21 - 23, 2016
Featuring: Peder Olofsson (Karolinska Institutet) and Kevin J. Tracey (The Feinstein Institute for Medical Research)
Bioelectronic medicine, a new discipline aimed at interfacing electronics with cells to target molecular mechanisms, is at the epicenter of healthcare, technology, and science. This symposium will advance the technological promise of bioelectronics.
Friday, October 7, 2016 | 9:00 AM - 5:00 PM
Mental illness causes debilitating consequences on quality of life for individuals, families, and society. This symposium explores avenues for translating these discoveries about the neurobiology of a spectrum of mental illnesses into new treatments.
Tuesday, June 28, 2016 | 8:00 AM - 5:30 PM
Keynote Speaker: Giancarlo Comi (Università Vita-Salute San Raffaele)
Explore novel and emerging treatments for multiple sclerosis, including biomarkers and MRI usage in disease diagnosis, prognosis, and monitoring.
Tuesday, June 21, 2016 | 8:30 AM - 5:00 PM
Keynote Speaker: Sharon Inouye (Harvard Medical School)
This meeting will convene leading scientists and physicians to discuss the challenges and opportunities to create biomarkers and therapeutics for these patients who are vulnerable to delirium, cognitive decline, and dementia following surgery.
Monday, June 13, 2016 | 10:00 AM - 3:30 PM
Speakers: Ruslan M. Medzhitov (Yale School of Medicine, Howard Hughes Medical Institute), Mauro Perretti (The William Harvey Research Institute, Queen Mary University of London), Charles N. Serhan (Brigham and Women's Hospital & Harvard Medical School), Lars Klareskog (Karolinska Institutet), and Kevin J. Tracey (The Feinstein Institute for Medical Research)
This symposium will honor Dr. Charles N. Serhan, the recipient of the 2016 Ross Prize in Molecular Medicine, for his important discoveries in identifying bioactive mediators and cellular pathways critical in the resolution of inflammatory diseases.
Wednesday, May 18, 2016 | 5:45 PM - 7:00 PM
Moderator: Claudia Wallis (Scientific American Mind)
Panelists: Jeremy Waletzky (The George Washington University), Nora D. Volkow (NIH), Cheryl Healton (College of Global Public Health, New York University), and Honorable Gregory P. Canova, JD
1.3 million adolescents in the US have substance use disorder and marijuana use among teens now exceeds cigarette smoking. Join us for a public panel discussion on how neuroscience intersects with policy to improve lives of teens with addiction.
Organizers: Renier Brentjens (Memorial Sloan Kettering Cancer Center), George Zavoico (Jones Trading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
This eBriefing explores advances in cancer immunotherapy, which engages the immune system to detect and destroy cancer cells and has gained popularity and success in recent years.
Edited by Annals of the New York Academy of Sciences
Recent discoveries in lysosome biology and the therapeutic potential of drugs targeting the lysosome in various diseases.
Organizers: Jane S. Lebkowski (Asterias Biotherapeutics), George Zavoico (JonesTrading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
This eBriefing considers efforts to rethink clinical, regulatory, and manufacturing approaches to accelerate the transition of cell-based therapies to the clinic.
Edited by Lothar Kanz
(University of Tübingen, Tübingen, Germany), Willem E. Fibbe
(Leiden University Medical Center, Leiden, the Netherlands), Julia Skokowa
(University Hospital Tübingen, Tübingen, Germany), and John E. Dick
(University of Toronto, Toronto, Ontario, Canada)
Commissioned review articles discuss various properites of blood stem cells